PatientsVille.com Logo

PatientsVille

Fosavance Side Effects

Common Fosavance Side Effects


The most commonly reported Fosavance side effects (click to view or check a box to report):

Osteonecrosis (13)
Femur Fracture (8)
Osteonecrosis Of Jaw (7)
Myalgia (6)
Pain (5)
Bone Pain (5)
Anaemia (5)
Arthralgia (4)
Headache (4)
Joint Swelling (4)
Pain In Extremity (4)
Death (3)
Atypical Femur Fracture (3)
Foot Fracture (3)
Cardiac Arrest (3)
Movement Disorder (3)
Pathological Fracture (3)
Pancreatitis Acute (3)
Myocardial Infarction (3)
Fracture (3)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Fosavance Side Effects Reported to FDA

The following Fosavance reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Fosavance on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Pain, Dry Skin, Dizziness, Headache, Nausea
This is a report of a 67-year-old female patient (weight: NA) from CA, suffering from the following symptoms/conditions: NA, who was treated with Fosavance (dosage: 1 Df, Unk, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Pain
  • Dry Skin
  • Dizziness
  • Headache
  • Nausea
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Fosavance treatment in female patients, resulting in pain side effect.


This report suggests a potential Fosavance side effect(s) that can have serious consequences. A 94-year-old female patient (weight: NA) from PH was diagnosed with the following symptoms/conditions: NA and used Fosavance (dosage: 1 Df, Qw) starting Oct 30, 2012. Soon after starting Fosavance the patient began experiencing various side effects, including:
    Drugs used concurrently: NA. Although Fosavance demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as death, may still occur.

    Osteonecrosis
    This Osteonecrosis problem was reported by a health professional from FR. A 70-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: osteoporosis. On 2008 this consumer started treatment with Fosavance (dosage: 70 Mg, Qw). The following drugs were being taken at the same time:
    • Temerit (5 Mg, Qd)
    When commencing Fosavance, the patient experienced the following unwanted symptoms/side effects:
    • Osteonecrosis
    The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as osteonecrosis, may become evident only after a product is in use by the general population.

    Mastectomy, Breast Cancer
    This is a report of a 54-year-old female patient (weight: NA) from CA. The patient developed the following symptoms/conditions: osteoporosis and was treated with Fosavance (dosage: 1 Df, Qw) starting Oct 03, 2012. Concurrently used drugs:
    • Advair
    • Ezetrol
    • Estradot
    • Provera
    Soon after that, the consumer experienced the following side effects:
    • Mastectomy
    • Breast Cancer
    The patient was hospitalized. This opens a possibility that Fosavance treatment could cause the above reactions, including mastectomy, and some female subjects may be more susceptible.


    Syncope
    A 56-year-old female patient (weight: NA) from ES with the following symptoms/conditions: osteoporosis started Fosavance treatment (dosage: 70 Mg/2.800 Ui, 1 Df, Qw) on Nov 04, 2013. Soon after starting Fosavance treatment, the subject experienced various side effects, including:
    • Syncope
    Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Fosavance.

    Eye Pain, Abdominal Distension, Abdominal Pain, Arthralgia, Bone Pain, Constipation, Flatulence, Headache, Myalgia
    A 64-year-old female patient from CA (weight: NA) experienced symptoms, such as: NA and was treated with Fosavance(dosage: 1 Df, 1 Every 1 Week). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
    • Eye Pain
    • Abdominal Distension
    • Abdominal Pain
    • Arthralgia
    • Bone Pain
    • Constipation
    • Flatulence
    • Headache
    • Myalgia
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Fosavance efficacy:
    • Effexor Xr
    • Trazodone Hydrochloride


    Osteonecrosis
    In this report, Fosavance was administered for the following condition: osteoporosis.A 77-year-old female consumer from IT (weight: NA) started Fosavance treatment (dosage: Unk) on 2002.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Osteonecrosis
    A possible interaction with other drugs could have contributed to this reaction:
    • Losartan Potassium (Unk)
    • Hydrochlorothiazide
    • Lansoprazole
    • Cardirene
    • Sequacor
    • Zuglimet
    Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Fosavance treatment could be related to the listed above side effect(s).

    Movement Disorder, Dyskinesia
    This is a report of the following Fosavance side effect(s):
    • Movement Disorder
    • Dyskinesia
    A 83-year-old female patient from ES (weight: NA) presented with the following condition: osteoporosis and received a treatment with Fosavance (dosage: Strength 70 Mg/2.800 Ui; 70 Mg, Qw) starting: Oct 01, 2012.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Fosavance treatment could be associated with the listed above side effect(s).

    Movement Disorder, Head Titubation
    This Fosavance report was submitted by a 54-year-old female consumer from ES (weight: NA). The patient was diagnosed with: osteoporosis and Fosavance was administered (dosage: 70 Mg/2.800 Ui, 70 Mg Qw) starting: 2003. The consumer developed a set of symptoms:
    • Movement Disorder
    • Head Titubation
    Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Fosavance treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

    Acute Myocardial Infarction, Local Swelling, Joint Swelling, Dyspepsia, Dysphagia
    This is a report of a possible correlation between Fosavance use and the following symptoms/side effect(s):
    • Acute Myocardial Infarction
    • Local Swelling
    • Joint Swelling
    • Dyspepsia
    • Dysphagia
    which could contribute to an assessment of Fosavance risk profile.A 75-year-old male consumer from DE (weight: NA) was suffering from osteoporosis,rheumatoid arthritis,atrial fibrillation and was treated with Fosavance (dosage: 70mg/5600lu, Qw) starting May 23, 2005.Other concurrent medications:
    • Methotrexate (Unk, Qw)
    • Pradaxa (110 Mg, Bid)
    • Urbason (6 Mg, Qd)
    • Tilidin (Solution, Prn)
    • Folic Acid (5 Mg, Qw)


    Breast Cancer, Tooth Disorder
    A female patient from FR (weight: NA) presented with the following symptoms: osteoporosis and after a treatment with Fosavance (dosage: 1 Df, Qd) experienced the following side effect(s):
    • Breast Cancer
    • Tooth Disorder
    The treatment was started on 2000. Fosavance was used in combination with the following drugs: NA.This report could alert potential Fosavance consumers.

    Hip Fracture, Fall
    In this report, a 63-year-old female patient from CA (weight: NA) was affected by a possible Fosavance side effect.The patient was diagnosed with osteoporosis. After a treatment with Fosavance (dosage: NA, start date: NS), the patient experienced the following side effect(s):
    • Hip Fracture
    • Fall
    The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Fosavance treatment.

    Pneumonia
    This is a report of a 83-year-old female patient from PH (weight: NA), who used Fosavance (dosage: 1 Df, Qw) for a treatment of NA. After starting a treatment on Nov 19, 2012, the patient experienced the following side effect(s):
    • Pneumonia
    The following drugs could possibly have interacted with the Fosavance treatment NA.Taken together, these observations suggest that a Fosavance treatment could be related to side effect(s), such as Pneumonia.

    Osteonecrosis
    This osteonecrosis side effect was reported by a physician from IT. A 83-year-old female patient (weight:NA) experienced the following symptoms/conditions: osteoporosis. The patient was prescribed Fosavance (dosage: 1 Df, Qw), which was started on Jan 01, 2007. Concurrently used drugs:
    • Citalopram
    • Serenase (Unk, Prn)
    • Spiriva
    • Talofen
    • Foradil
    • Depakine Chrono
    • Exelon (rivastigmine)
    • Entumine (Unk, Prn)
    When starting to take Fosavance the consumer reported the following symptoms:
    • Osteonecrosis
    These side effects may potentially be related to Fosavance.

    Femur Fracture
    This is a Fosavance side effect report of a 58-year-old female patient (weight:NA) from CH, suffering from the following symptoms/conditions: prophylaxis, who was treated with Fosavance (dosage:Unk, Qw, start time: Jul 01, 2010), combined with:
    • Voltfast (50 Mg, Qd)
    • Dafalgan (1 G, Prn)
    • Coaprovel (1 Df, Qd)
    • Calcimagon D3
    • Riopan (Unk, Prn)
    • Spiriva (Unk, Prn)
    , and developed a serious reaction and a femur fracture side effect. The patient presented with:
    • Femur Fracture
    which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Fosavance treatment in female patients suffering from prophylaxis, resulting in femur fracture.

    Rectal Haemorrhage, Anaemia, Melaena, Duodenal Ulcer
    This report suggests a potential Fosavance rectal haemorrhage side effect(s) that can have serious consequences. A 85-year-old female patient from FR (weight:NA) was diagnosed with the following health condition(s): osteoporosis,atrial fibrillation,lung disorder and used Fosavance (dosage: Unk) starting 201306. Soon after starting Fosavance the patient began experiencing various side effects, including:
    • Rectal Haemorrhage
    • Anaemia
    • Melaena
    • Duodenal Ulcer
    Drugs used concurrently:
    • Coumadin (Unk)
    • Augmentin (3 G, Qd)
    • Cordarone (1 Df, Qd)
    • Spiriva (Unk)
    • Seretide (1 Df, Bid)
    • Melaxose
    • Uvedose (Unk)
    • Lasilix (1 Df, Qd)
    The patient was hospitalized. Although Fosavance demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as rectal haemorrhage, may still occur.

    Tibia Fracture, Bone Pain
    This tibia fracture problem was reported by a physician from PT. A 57-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On 201210 a consumer started treatment with Fosavance (dosage: Unk). The following drugs/medications were being taken at the same time: NA. When commencing Fosavance, the patient experienced the following unwanted symptoms /side effects:
    • Tibia Fracture
    • Bone Pain
    Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as tibia fracture, may become evident only after a product is in use by the general population.

    Condition Aggravated, Photophobia, Vision Blurred
    This is a Fosavance side effect report of a 80-year-old female patient (weight: NA) from CA. The patient developed the following symptoms/conditions: NA and was treated with Fosavance (dosage: 1 Df, Qw) starting NS. Concurrently used drugs:
    • Adalat Xl
    • Aspirin
    Soon after that, the consumer experienced the following of symptoms:
    • Condition Aggravated
    • Photophobia
    • Vision Blurred
    This opens a possibility that Fosavance could cause condition aggravated and that some female patients may be more susceptible.

    Arthritis, Bone Disorder, Bone Pain, Condition Aggravated, Gait Disturbance, Hypoaesthesia, Pain In Extremity, Suicidal Ideation
    A 76-year-old female patient (weight: NA) from CA with the following symptoms: NA started Fosavance treatment (dosage: 1 Df, Qw) on NS. Soon after starting Fosavance treatment, the consumer experienced several side effects, including:
    • Arthritis
    • Bone Disorder
    • Bone Pain
    • Condition Aggravated
    • Gait Disturbance
    • Hypoaesthesia
    • Pain In Extremity
    • Suicidal Ideation
    . Concurrently used drugs:
    • Apo Lansoprazole
    • Folic Acid (Unk)
    • Micardis
    • Hydrazide (hydrochlorothiazide)
    • Cyanocobalamin
    This finding indicates that some patients can be more vulnerable to developing Fosavance side effects, such as arthritis.

    Activities Of Daily Living Impaired, Skin Burning Sensation, Skin Fissures, Skin Plaque
    This activities of daily living impaired side effect was reported by a consumer or non-health professional from CA. A 76-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Fosavance (dosage: 70 Mg, Qw), which was started on NS. Concurrently used drugs:
    • Bromazepam
    • Atorvastatin Calcium
    .When starting to take Fosavance the consumer reported symptoms, such as:
    • Activities Of Daily Living Impaired
    • Skin Burning Sensation
    • Skin Fissures
    • Skin Plaque
    These side effects may potentially be related to Fosavance.

    Contusion, Joint Swelling, Musculoskeletal Pain
    This is a report of a 85-year-old male patient (weight: NA) from CA, suffering from the following symptoms/conditions: NA, who was treated with Fosavance (dosage: 1 Df, Qw, start time: NS), combined with:
    • Depo-medrol
    • Flomax (tamsulosin Hydrochloride)
    and developed a serious reaction and side effect(s). The consumer presented with:
    • Contusion
    • Joint Swelling
    • Musculoskeletal Pain
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Fosavance treatment in male patients, resulting in contusion side effect. The patient was hospitalized.

    Fatigue, Ligament Calcification, Myalgia
    This report suggests a potential Fosavance Fatigue, Ligament Calcification, Myalgia side effect(s) that can have serious consequences. A 74-year-old female patient (weight: NA) from CA was diagnosed with the following symptoms/conditions: NA and used Fosavance (dosage: 1 Df, Qw) starting NS. Soon after starting Fosavance the patient began experiencing various side effects, including:
    • Fatigue
    • Ligament Calcification
    • Myalgia
    Drugs used concurrently:
    • Apo Pravastatin
    Although Fosavance demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as fatigue, may still occur.

    Arthralgia, Eye Discharge, Ocular Hyperaemia
    This Arthralgia, Eye Discharge, Ocular Hyperaemia problem was reported by a health professional from CA. A 82-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Fosavance (dosage: 1 Df, Qw). The following drugs were being taken at the same time:
    • Adalat Xl
    When commencing Fosavance, the patient experienced the following unwanted symptoms/side effects:
    • Arthralgia
    • Eye Discharge
    • Ocular Hyperaemia
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as arthralgia, may become evident only after a product is in use by the general population.


    This is a report of a 69-year-old female patient (weight: NA) from CA. The patient developed the following symptoms/conditions: osteoporosis and was treated with Fosavance (dosage: 70 Mg, Qw) starting 200708. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
      This opens a possibility that Fosavance treatment could cause the above reactions, including death, and some female subjects may be more susceptible.

      Cardiac Arrest
      A 85-year-old female patient (weight: NA) from PH with the following symptoms/conditions: NA started Fosavance treatment (dosage: 1 Df, Qw) on NS. Soon after starting Fosavance treatment, the subject experienced various side effects, including:
      • Cardiac Arrest
      Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Fosavance.

      1 of 5 



      Top 10 Fosavance Side Effects for Women

      Women Side EffectsReports
      Osteonecrosis 12
      Femur Fracture 8
      Osteonecrosis Of Jaw 7
      Myalgia 6
      Anaemia 5
      Bone Pain 5
      Pain 5
      Arthralgia 4
      Headache 4
      Pain In Extremity 4

      Keep Track of Side Effects

      Note Your Observations

      It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

      Why Your Notes are Important

      Your notes could be helpful in several ways:

    • You can use them to remind you of details that may alert your health care professional(s) to a problem
    • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

    • Log Form

      You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

      Medicine Name and Dosage:
      Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
      Scale: 1 = very mild to 10 = very bad

      You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


      Discuss Fosavance Side Effects

      Did You Have a Fosavance Side Effect?

      Yes, Severe
      Yes, Moderate
      Yes, Minor
      No

      How Effective is Fosavance for You?

      Exceeded Expectations
      Effective
      Somewhat Effective
      Not Effective